Trial Profile
A Phase I trial evaluating safety of 4-1BB CTL in terminally ill cancer patients.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 19 Jan 2017
Price :
$35
*
At a glance
- Drugs Epstein-Barr-virus-induced-adoptive-T-Cell-Therapy-Eutilex (Primary)
- Indications Cancer
- Focus Adverse reactions
- 19 Jan 2017 New trial record